Skip to Content

SEC Filing Details

Document Details

Form
Filing Date
Jun 14, 2023
Document Date
Jun 12, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Cerevel Therapeutics
Issuer
CEREVEL THERAPEUTICS HOLDINGS, INC.
Filer
Renaud Ronald C JR

Cerevel is now part of AbbVie

Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.

Read the press release